Showing results (1601-1610 of 2,323) with videos related to

Sort By:
Pageof 233
Expert Opinion on Therapeutic Targets|October 28, 2017
Targeting IL-33/ST2 signaling: regulation of immune function and analgesiaVictor Fattori, Miriam S N Hohmann, Ana C Rossaneis, et al.
Expert Opinion on Therapeutic Targets|May 16, 2022
Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscapeXuemei Xie, Jangsoon Lee, Toshiaki Iwase, et al.
Expert Opinion on Therapeutic Targets|May 18, 2022
Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson's diseaseXiaoyan Yang, Peng Feng, Rong Ji, et al.
Expert Opinion on Therapeutic Targets|July 22, 2021
Redox-sensitive TRP channels: a promising pharmacological target in chemotherapy-induced peripheral neuropathyRamandeep Singh, Pratik Adhya, Shyam Sunder Sharma
Expert Opinion on Therapeutic Targets|June 8, 2021
Peripheral vascular disease: preclinical models and emerging therapeutic targeting of the vascular endothelial growth factor ligand-receptor systemVijay Chaitanya Ganta, Brian H Annex
Expert Opinion on Therapeutic Targets|March 20, 2020
Mechanisms underlying priapism in sickle cell disease: targeting and key innovations on the preclinical landscapeBiljana Musicki, Arthur L Burnett
Expert Opinion on Therapeutic Targets|March 20, 2020
An expert update on novel therapeutic targets for hyperphosphatemia in chronic kidney disease: preclinical and clinical innovationsMario Cozzolino, Markus Ketteler, Carsten Alexander Wagner
Expert Opinion on Therapeutic Targets|April 7, 2020
Emerging therapeutic targets for nasopharyngeal carcinoma: opportunities and challengesValentin Baloche, François-Régis Ferrand, Anna Makowska, et al.
Expert Opinion on Therapeutic Targets|April 7, 2020
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targetsRosamaria Lappano, Damiano Cosimo Rigiracciolo, Antonino Belfiore, et al.
Expert Opinion on Therapeutic Targets|January 5, 2020
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targetingAlessandra Musella, Diego Fresegna, Francesca Romana Rizzo, et al.
Pageof 233